UNIVERSITE FRANCOIS RABELAIS Patent applications |
Patent application number | Title | Published |
20160118485 | HIGH-VOLTAGE VERTICAL POWER COMPONENT - A vertical power component includes a silicon substrate of a first conductivity type with a well of the second conductivity type on a lower surface of the substrate. The first well is bordered at a component periphery with an insulating porous silicon ring. An upper surface of the porous silicon ring is only in contact with the substrate of the first conductivity type. The insulating porous silicon ring penetrates into the substrate down to a depth greater than a thickness of the well. | 04-28-2016 |
20150187514 | COMPOSITION COMPRISING A SPECIFIC IONIC LIQUID - The invention relates to a composition comprising an ionic liquid consisting in the combination of a pyrrolidinium cation and a nitrate anion and comprising a solvent selected from lactone solvents, carbonate solvents, nitrile solvents and mixtures thereof. The composition may be used as an electrolyte, for example, for such applications as energy storage devices. | 07-02-2015 |
20150108537 | HIGH-VOLTAGE VERTICAL POWER COMPONENT - A vertical power component includes a silicon substrate of a first conductivity type with a well of the second conductivity type on a lower surface of the substrate. The first well is bordered at a component periphery with an insulating porous silicon ring. An upper surface of the porous silicon ring is only in contact with the substrate of the first conductivity type. The insulating porous silicon ring penetrates into the substrate down to a depth greater than a thickness of the well. | 04-23-2015 |
20140217462 | VERTICAL POWER COMPONENT - A high-voltage vertical power component including a silicon substrate of a first conductivity type, and a first semiconductor layer of the second conductivity type extending into the silicon substrate from an upper surface of the silicon substrate, wherein the component periphery includes: a porous silicon ring extending into the silicon substrate from the upper surface to a depth deeper than the first layer; and a doped ring of the second conductivity type, extending from a lower surface of the silicon surface to the porous silicon ring. | 08-07-2014 |
20140175326 | SPECIFIC ELECTROLYTIC COMPOSITION FOR ENERGY STORAGE DEVICE - This invention relates to an electrolytic composition comprising at least one organic solvent in which one or several non-lithiated ionic salts are dissolved, characterised in that an ionic liquid is added to this electrolytic composition. | 06-26-2014 |
20140168855 | NOVEL IONIC LIQUIDS THAT CAN BE USED AS PART OF THE ELECTROLYTE COMPOSITION FOR ENERGY STORAGE DEVICES - The present invention relates to ionic liquids comprising, as cation, a specific phosphonium cation, as anion, a formiate anion, which can be used, alone or as a mixture, to constitute electrolytes for energy storage devices. | 06-19-2014 |
20140035132 | SURFACE MOUNT CHIP - A surface mount chip including, on the side of a surface, first and second pads of connection to an external device, wherein, in top view, the first pad has an elongated general shape, and the second pad is a point-shaped pad which is not aligned with the first pad. | 02-06-2014 |
20130320395 | HIGH-VOLTAGE VERTICAL POWER COMPONENT - A vertical power component including: a silicon substrate of a first conductivity type; on the side of a lower surface of the substrate supporting a single electrode, a lower layer of the second conductivity type; and on the side of an upper surface of the substrate supporting a conduction electrode and a gate electrode, an upper region of the second conductivity type, wherein the component periphery includes, on the lower surface side, a porous silicon insulating ring penetrating into the substrate down to a depth greater than that of the lower layer. | 12-05-2013 |
20130189586 | METHOD FOR PREPARING A COMPOSITE, COMPOSITE THUS OBTAINED AND USES THEREOF - The present invention concerns a method for preparing a composite material comprising electrically conductive or semiconductive nano-objects of elongate shape and an electrically conductive polymer matrix, said method comprising a step consisting in electrochemically deposing said matrix on said nano-objects using a pulsed galvanostatic technique. The present invention also concerns the composite material thus obtained and uses thereof. | 07-25-2013 |
20130135970 | Galvanically-Isolated Data Transmission Device - A data transmission device includes a coder configured to code the data into a multifrequency signal. A first array of ultrasonic transducers with a vibrating membrane is disposed on a first surface of a wafer. The first array configured to convert the signal into a multifrequency acoustic signal propagating in the wafer. A second array of ultrasonic transducers is disposed on a second surface of the wafer. The second array includes at least two assemblies of vibrating membrane ultrasonic transducers having resonance frequencies equal to two different frequencies of the multifrequency signal. | 05-30-2013 |
20130008437 | DEVICE FOR ORAL ADMINISTRATION OF AN AEROSOL FOR THE RHINOPHARYNX, THE NASAL CAVITIES OR THE PARANASAL SINUSES - A device for administration of an aerosol includes a generator of particles of size between 10 nm and 200 um, a mouthpiece or mouth mask for oral administration of the aerosol during the nasal exhalation phase or during the respiratory pause phase preceding nasal exhalation, and a source of gas or pressure for conveying the particles. The mouthpiece is airtight, extends beyond the teeth of the patient by a maximum length of 4 cm, and administers the aerosol for the nasal cavities, the rhinopharynx or the paranasal sinuses during aerosol administration phases, such that the is successively applied to the mouth, the rhinopharynx and then the nasal fossae and the sinuses, and then the aerosol escapes via one or both of the patient's nostril. The device does not allow exhalation via the mouth during aerosol administration phases, and the aerosol particles not being directed to the lungs. | 01-10-2013 |
20120295261 | METHOD FOR THE IN VITRO DIAGNOSIS OF BRONCHOPULMONARY CARCINOMA BY DETECTION OF MAJOR ALTERNATIVE TRANSCRIPTS OF THE KLK8 GENE ENCODING KALLICREIN 8 AND USE THEREOF FOR PROGNOSTICATING SURVIVAL - A method for the in vitro diagnosis of bronchopulmonary carcinoma, in particular of non-small cell bronchial carcinoma, that includes a stage of detecting, in a biological sample derived from a patient suspected to be suffering from bronchopulmonary carcinoma, at least one of the major alternative transcripts of the KLK8 gene encoding kallikrein 8. This method is particularly useful for the survival prognostication of patients suffering from bronchopulmonary carcinoma. | 11-22-2012 |
20100255466 | Method for the in vitro diagnosis of bronchopulmonary carcinoma by detection of major alternative transcripts of the klk8 gene encoding kallicrein 8 and use thereof for prognosticating survival - The present invention relates to a method for the in vitro diagnosis of bronchopulmonary carcinoma, in particular of non-small cell bronchial carcinoma, characterized in that it comprises the stage of detecting, in a biological sample derived from a patient suspected to be suffering from said bronchopulmonary carcinoma, at least one of the major alternative transcripts of the KLK8 gene encoding kallikrein 8. This method is particularly useful for the survival prognostication of patients suffering from bronchopulmonary carcinoma. | 10-07-2010 |
20100167315 | METHOD FOR INVESTIGATING THE RESPONSE TO A TREATMENT WITH A MONOCLONAL ANTIBODY - The invention relates to steps for the development or the quality control of recombinant monoclonal antibodies (MoAbr) used as medicaments, and also to the selection of the patients liable to effectively respond to a treatment with a given monoclonal antibody. More specifically, the invention relates to a method for evaluating, in vitro, the effector functions of NK cells in response to a test monoclonal antibody, comprising at least the following steps: (i) the NK cells are brought into contact with said monoclonal antibody, which is fixed on a support, in the presence of an agent for inhibiting the secretion of cytokines by said cells; (ii) by way of positive control for the activation of the NK cells, the same experiment is carried out using, in place of the test monoclonal antibody, a monoclonal antibody directed against the Fc RIIIa receptor; (iii) after an incubation period of at least 1 hour, the response of the NK cells is observed by measuring the presence of the CD107 marker at the cell surface, and also the presence of intracellular IFN and/or of intracellular TNF. | 07-01-2010 |